+ All Categories
Home > Documents > Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications:...

Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications:...

Date post: 26-Oct-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
13
Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch, Islamic Azad University, Tehran, Iran Phone: 021-44865777 Email:[email protected], [email protected] Educational Qualifications: Ph.D of Molecular Genetics, Science and Research Branch, Islamic Azad University, 2008. M.Sc degree of Genetic, Shahid Beheshti University, Tehran, Iran, 2003 B.Sc degree Tehran University, Tehran, Iran, 1992 Research Interests: Cancer gene therapy Gene expression Cell behavior study in tissue engineering Teaching: Gene Regulation Genetics of Cancer Molecular Genetics Genetic Engineering Gene Therapy Biotechnology Cell culture Research Projects: 1) Isolation, cloning and expression of monooxigenase gene from a newly isolated strain (Rhodococcous FMF) in Iran. (2001-2003) 2) Production of polyhydroxy alkanoates from micro-organisms .(2003-2006) 3) Nerve tissue engineering (2006 -2009). 4) Synthesis of nanocomposite poly (HB-co-HV) for tissue engineering (2009-2011). 5) Study of cell behavior on N- isobromilacrylamide/ poly grafting (2011-2012). 6) Breast cancer cells treatment by plasma radiation and targeting dextran- doxorubicin/ chitosan nanoparticles ( 2014). 7) Study of LNCRNAs Linc-ROR&psor1c expression and function in Glioma cancer stem cells treated by PLGAPEG nanoparticles for dual drug delivery of SN38/Verapamil (2016-2018).
Transcript
Page 1: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

Shiva Irani

(B.Sc., M.Sc., PhD)

Science and Research Branch, Islamic Azad University, Tehran, Iran

Phone: 021-44865777

Email:[email protected], [email protected]

Educational Qualifications:

Ph.D of Molecular Genetics, Science and Research Branch, Islamic Azad

University, 2008.

M.Sc degree of Genetic, Shahid Beheshti University, Tehran, Iran, 2003

B.Sc degree Tehran University, Tehran, Iran, 1992

Research Interests:

Cancer gene therapy

Gene expression

Cell behavior study in tissue engineering

Teaching:

Gene Regulation

Genetics of Cancer

Molecular Genetics

Genetic Engineering

Gene Therapy

Biotechnology

Cell culture

Research Projects:

1) Isolation, cloning and expression of monooxigenase gene from a newly isolated strain

(Rhodococcous FMF) in Iran. (2001-2003)

2) Production of polyhydroxy alkanoates from micro-organisms .(2003-2006)

3) Nerve tissue engineering (2006 -2009).

4) Synthesis of nanocomposite poly (HB-co-HV) for tissue engineering (2009-2011).

5) Study of cell behavior on N- isobromilacrylamide/ poly grafting (2011-2012).

6) Breast cancer cells treatment by plasma radiation and targeting dextran- doxorubicin/

chitosan nanoparticles ( 2014).

7) Study of LNCRNAs Linc-ROR&psor1c expression and function in Glioma cancer

stem cells treated by PLGAPEG nanoparticles for dual drug delivery of

SN38/Verapamil (2016-2018).

Page 2: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

8) In vivo and in vitro evaluation of immobilized protein BMP2 impact on electrospun

PCL/CMC blend using cold atmospheric pressure plasma jet for bone tissue

engineering. ( 2016-2018)

9) Study of electrospun poly caprolactone-beta carotene scaffolds modified by cold

atmospheric plasma for bone tissue engineering in in vitro condition (2016-2018).

10) Three-dimensional (3D) biodegradable scaffold containing -caroten for neural

differentiation of ips cells based on crisper/cos9 directed genome editing (started)

11) Immobilization of designed peptide on electrospun poly seter- natural biomaterial

blend by cold atmospheric atmospheric pressure plasma jet for bone tissue

engineering application and its in vivo/in vitro evaluation (started)

Patent:

Synthesis of medium chain length polyhydroxyalkanoate(mclPHA) by a

native Pseudomonas strain.

Publications:

Journal Articles.

1. Badi SA, Khatami S, Irani S, Siadat SD. Induction Effects of Bacteroides

fragilis Derived Outer Membrane Vesicles on Toll Like Receptor 2, Toll Like

Receptor 4 Genes Expression and Cytokines Concentration in Human

Intestinal Epithelial Cells. Cell Journal (Yakhteh). 2019 Apr 1;12(1).

IF:2.363

2. Ayadi A, Nafari AH, Irani S, Mohebbi E, Mohebbi F, Sakhaee F, Vaziri F,

Siadat SD, Fateh A. Occult hepatitis C virus infection in patients with

beta‐thalassemia major: Is it a neglected and unexplained phenomenon?.

Journal of cellular biochemistry. 2019 Jul;120(7):11908-14. IF: 2.959

3. Alizadeh S, Irani S, Bolhassani A, Sadat SM. Simultaneous use of natural

adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific

immune responses. Immunology Letters. 2019 Jun 26. IF:2.436

4. Rostami B, Irani S, Bolhassani A, Cohan RA. Gene and protein delivery using

four cell penetrating peptides for HIV‐1 vaccine development. IUBMB life.

2019 Jun 20. IF:3.051

Page 3: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

5. Meghdadi M, Pezeshki-Modaress M, Irani S, Atyabi SM, Zandi M.

Chondroitin sulfate immobilized PCL nanofibers enhance chondrogenic

differentiation of mesenchymal stem cells. International journal of biological

macromolecules. 2019 Jun 15. IF: 4.784

6. Naddafnia H, Noormohammadi Z, Irani S, Salahshoorifar I. Frequency of

GJB2 mutations, GJB6‐D13S1830 and GJB6‐D13S1854 deletions among

patients with non‐syndromic hearing loss from the central region of Iran.

Molecular genetics & genomic medicine. 2019 Jun 4:e780. IF: 2.448

7. Kalhori MR, Soleimani M, Irani S. MiR-16 induces G1 cell cycle arrest and

apoptosis in acute myeloid leukemia cells. Gene Reports. 2019 Jun

1;15:100399. IF: 0.176

8. Asadiyun M, Ahangari N, Ardebili ME, Irani S, Houshmand M. DISC1 4 bp

deletion in association with schizophrenic patients. Meta Gene. 2019 Jun

1;20:100563. IF:0.625

9. Alemi PS, Atyabi SA, Sharifi F, Mohamadali M, Irani S, Bakhshi H, Atyabi

SM. Synergistic effect of pressure cold atmospheric plasma and

carboxymethyl chitosan to mesenchymal stem cell differentiation on

PCL/CMC nanofibers for cartilage tissue engineering. Polymers for

Advanced Technologies. 2019 Jun;30(6):1356-64. IF:2.137

10. Kamalzare S, Noormohammadi Z, Rahimi P, Atyabi F, Irani S, Tekie FS,

Mottaghitalab F. Carboxymethyl dextran‐trimethyl chitosan coated

superparamagnetic iron oxide nanoparticles: An effective siRNA delivery

system for HIV‐1 Nef. Journal of cellular physiology. 2019 May 29. IF:

4.522

11. Kabiri L, Irani S, Nikpoor AR, Afshari JT. Inhibitory and Apoptotic Effects

of Mannan-Mitomycin C Conjugate Against Transitional Cell Carcinoma and

Normal Mouse Fibroblasts. Reports of Biochemistry and Molecular Biology.

2019 May 15;8(1):63-71.

12. Samimi H, Haghpanah V, Irani S, Arefian E, Sohi AN, Fallah P, Soleimani

M. Transcript-level regulation of MALAT1-mediated cell cycle and

apoptosis genes using dual MEK/Aurora kinase inhibitor “BI-847325” on

anaplastic thyroid carcinoma. DARU Journal of Pharmaceutical Sciences.

2019 May 10:1-7. IF:2.667

13. Mohsenpour M, Noormohammadi Z, Irani S, Amirmozafari N. Expression of

an Environmentally Friendly Enzyme, Engineered Carbonic Anhydrase, in

Escherichia coli. International Journal of Environmental Research. 2019 Apr

1;13(2):295-301. IF:1.019

14. Arabahmadi S, Pezeshki Modaress M, Irani S, Zandi M. Electrospun

biocompatible Gelatin-Chitosan/Polycaprolactone/Hydroxyapatite

nanocomposite scaffold for bone tissue engineering. International Journal of

Nano Dimension. 2019 Apr 1;10(2):169-79. IF: 0.766

Page 4: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

15. Soltani-Sedeh H, Irani S, Mirfakhraie R, Soleimani M. Potential using of

microRNA-34A in combination with paclitaxel in colorectal cancer cells.

Journal of cancer research and therapeutics. 2019 Jan 1;15(1):32. IF: 0.791

16. AGHDAIE HA, Emami E, Nourian M, Chaleshi V, Tarban P, Balaii H,

Azimzadeh P, Irani S, Shahrokh S, Rostami-Nejad M, ZALI MR. Interleukin

12B mRNA level and rs3212227 genotyping in peripheral blood

mononuclear cells of inflammatory bowel disease patients. Turkish journal of

medical sciences. 2018 Dec 12;48(6):1147-52. IF: 0.603

17. Binaafar S, Kalani M, Nayeri F, Irani S, Salimi V, Shariat M, Niknafs N,

Dalili H, Amini E, Shirvani TE, Hardani AK. Evaluation of the Potential

Association Between Cannabinoid Receptor 2 Gene Q63R Polymorphism

(Rs35761398) and Risk of RDS Development in Preterm Neonates.

IRANIAN JOURNAL OF PEDIATRICS. 2018 Dec 1;28(6).

18. Sharifi F, Atyabi SM, Norouzian D, Zandi M, Irani S. Osteoblast cell

behavior on chitosan/poly caprolactone nanifiber for hard tissue engineering

application. MINERVA BIOTECNOLOGICA. 2018 Jun 1;30(2):51-7. IF:

0.596

19. Ahmadi H, Mirfakhraie R, Irani S. The relation between Y chromosome

microdeletions and recurrent pregnancy loss. Tehran University Medical

Journal TUMS Publications. 2018 Jan 15;75(10):730-7.

20. Owrang M, Fallah F, Irani S, Rahbar M, Eslami G. Identification and

Isolation of Insertion Sequences, in Carbapenem Resistant Clinical Isolates of

Acinetobacter baumannii from Tehran Hospitals. Jundishapur Journal of

Microbiology. 2018;11(6). IF:0.957

21. Vaezi M, Yaghmaei P, Hayati-Roodbari N, Irani S, Ebrahim-Habibi A. Citral

effect in male NMRI mice nonalcoholic steatosis model: assessing

biochemical and histological parameters and PPARα gene expression.

Brazilian Journal of Pharmaceutical Sciences. 2018;54(3).

22. Karimkhani S, Chaleshi V, Balaii H, Tarban P, Nourian M, Irani S, Shahrokh

S, Aghdaei HA, Alizadeh AH, Norouzinia M, Zali MR. Lack of Association

between Interleukin 23R (IL-23R) rs10889677 Polymorphism and

Inflammatory Bowel Disease Susceptibility In an Iranian Population. Reports

of biochemistry & molecular biology. 2018 Oct;7(1):16.

23. Kangarlouei R, Irani S, Noormohammadi Z, Memari F, Mirfakhraie R.

ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric

cancer. Journal of cellular biochemistry. 2019 Aug;120(8):12544-8. IF:2.959

24. Meghdadi M, Atyabi SM, Pezeshki-Modaress M, Irani S, Noormohammadi

Z, Zandi M. Cold atmospheric plasma as a promising approach for gelatin

immobilization on poly (ε-caprolactone) electrospun scaffolds. Progress in

biomaterials. 2019 Mar 27:1-1.

Page 5: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

25. Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K.

Corrigendum to “Potential circulating miRNA signature for early detection of

NSCLC”[Cancer Genetics 216–217 (2017) 150–158]. Cancer genetics. 2018

Dec 1;228:127. IF:2.183

26. Nafari M, Irani S, Vaziri F, Gharibzadeh S, Sakhaee F, Khazeni M, Kalhor N,

Jamnani FR, Siadat SD, Fateh A. Correlation of CD81 and SCARB1

polymorphisms on virological responses in Iranian patients with chronic

hepatitis C virus genotype 1. Infection, Genetics and Evolution. 2018 Aug

1;62:296-303. IF:2.5

27. Rostami B, Irani S, Bolhassani A, Cohan RA. M918: A Novel Cell

Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef

Proteins into Eukaryotic Cell Lines. Current HIV research. 2018 Jul

1;16(4):280-7. IF:1.562

28. Honarpour A, Mohseni M, Ghavidel Hajiagha S, Irani S, Najmabadi H.

Investigation of the Relationship Between a Genetic Polymorphism in

ACTN3 and Elite Sport Performance Among Iranian Soccer Players. Iranian

Rehabilitation Journal. 2017 Jun 15;15(2):149-54.

29. Owrang M, Eslami G, Fallah F, Irani S, Rahbar M. Molecular Detection of

ISAba2 among Carbapenem Hydrolyzing Class D β-Lactamasese

Acinetobacter baumannii Strains Isolated from Patients in Tehran Hospitals.

Iran. J. Med. Microbiol. 2017 Jan 1;11:19-26. IF:2.112

30. Ahmadi K, Soleimani A, Irani S, Kiani A, Ghanadi K, Noormohamadi Z,

Sakinejad F. DNMT3B− 579 G> T Promoter Polymorphism and the Risk of

Gastric Cancer in the West of Iran. Journal of gastrointestinal cancer. 2018

Jun 1;49(2):167-71.

31. Nagheh Z, Irani S, Mirfakhraie R, Dinarvand R. SN38-PEG-PLGA-

verapamil nanoparticles inhibit proliferation and downregulate drug

transporter ABCG2 gene expression in colorectal cancer cells. Progress in

biomaterials. 2017 Dec 1;6(4):137-45.

32. Khalighfard S, Alizadeh AM, Irani S, Omranipour R. Plasma miR-21, miR-

155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of

breast cancer patients. Scientific reports. 2018 Dec 19;8(1):17981. IF:4.525

33. Namini MS, Bayat N, Tajerian R, Ebrahimi-Barough S, Azami M, Irani S,

Jangjoo S, Shirian S, Ai J. A comparison study on the behavior of human

endometrial stem cell-derived osteoblast cells on PLGA/HA nanocomposite

scaffolds fabricated by electrospinning and freeze-drying methods. Journal of

orthopaedic surgery and research. 2018 Dec;13(1):63. IF:1.215

Page 6: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

34. Esmailian S, Irani S, Bakhshi H, Zandi M. Biodegradable bead-on-spring

nanofibers releasing β-carotene for bone tissue engineering. Materials

Science and Engineering: C. 2018 Nov 1;92:800-6. IF: 5.08

35. Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, Souri

E, Khoshayand MR, Esfandyari-Manesh M, Jafari RM, Atyabi F. Dual drug

delivery system of PLGA nanoparticles to reverse drug resistance by altering

BAX/Bcl-2. Journal of Drug Delivery Science and Technology. 2018 Oct

1;47:291-8. IF:2.606

36. Asgharkhani E, Azarbayjani AF, Irani S, Chiani M, Saffari Z, Norouzian D,

Akbarzadeh A, Atyabi SM. Artemisinin-loaded niosome and pegylated

niosome: physico-chemical characterization and effects on MCF-7 cell

proliferation. Journal of Pharmaceutical Investigation. 2018 May

1;48(3):251-6.

37. Irani S, Atyabi F. Comparison of cytotoxicity chitosan-docetaxel

nanoparticles and free drug on MDA-MB-231 breast cancer cells. Razi

Journal of Medical Sciences. 2016 Jun 15;23(144):9-18.

38. Sharifi F, Atyabi SM, Norouzian D, Zandi M, Irani S, Bakhshi H.

Polycaprolactone/carboxymethyl chitosan nanofibrous scaffolds for bone

tissue engineering application. International journal of biological

macromolecules. 2018 Aug 1;115:243-8. IF:4.784.

39. Fayez D, Saliminejad K, Irani S, Kamali K, Memariani T, Khorshid HR.

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of

Endometriosis. Avicenna journal of medical biotechnology. 2018

Jul;10(3):163.

40. Dabouian A, Bakhshi H, Irani S, Pezeshki-Modaress M. β-Carotene: a natural

osteogen to fabricate osteoinductive electrospun scaffolds. RSC advances.

2018 Mar 5;8(18):9941-5. IF: 3.049

41. Sedighimehr P, Irani S, Sakhaee F, Vaziri F, Aghasadeghi M, Sadat SM,

Jamnani FR, Fateh A, Siadat SD. IL28B rs12980275 and HLA rs4273729

genotypes as a powerful predictor factor for rapid, early, and sustained

virologic response in patients with chronic hepatitis C. Archives of virology.

2017 Jan 1;162(1):181-9. IF: 2.160.

42. Jeiranikhameneh M, Razavi MR, Irani S, Siadat SD, Oloomi M. Designing

novel construction for cell surface display of protein E on Escherichia coli

using non-classical pathway based on Lpp-OmpA. AMB Express. 2017 Dec

1;7(1):53. IF:2.226

43. Kadkhodayan S, Bolhassani A, Mehdi Sadat S, Irani S, Fotouhi F. The

efficiency of Tat cell penetrating peptide for intracellular uptake of HIV-1

Nef expressed in E. coli and mammalian cell. Current drug delivery. 2017

Jun 1;14(4):536-42. IF:1.645

Page 7: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

44. Mohamadali M, Irani S, Soleimani M, Hosseinzadeh S. PANi/PAN

copolymer as scaffolds for the muscle cell‐like differentiation of

mesenchymal stem cells. Polymers for Advanced Technologies. 2017

Sep;28(9):1078-87. IF:2.137

45. Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K.

Potential circulating miRNA signature for early detection of NSCLC. Cancer

genetics. 2017 Oct 1;216:150-8. IF:2.183

46. Shapourzadeh A, Rahimi-Verki N, Atyabi SM, Shams-Ghahfarokhi M,

Jahanshiri Z, Irani S, Razzaghi-Abyaneh M. Inhibitory effects of cold

atmospheric plasma on the growth, ergosterol biosynthesis, and keratinase

activity in Trichophyton rubrum. Archives of biochemistry and biophysics.

2016 Oct 15;608:27-33. IF:3.017

47. Pakfar A, Irani S, Hanaee-Ahvaz H. Expressions of pathologic markers in

PRP based chondrogenic differentiation of human adipose derived stem cells.

Tissue and Cell. 2017 Feb 1;49(1):122-30. IF:3.043

48. Dadras P, Atyabi F, Irani S, Ma'mani L, Foroumadi A, Mirzaie ZH, Ebrahimi

M, Dinarvand R. Formulation and evaluation of targeted nanoparticles for

breast cancer theranostic system. European Journal of Pharmaceutical

Sciences. 2017 Jan 15;97:47-54. IF:3.773

49. Sharifi F, Irani S, Zandi M, Soleimani M, Atyabi SM. Comparative of

fibroblast and osteoblast cells adhesion on surface modified nanofibrous

substrates based on polycaprolactone. Progress in biomaterials. 2016 Dec

1;5(3-4):213-22.

50. Kadkhodayan S, Sadat SM, Irani S, Fotouhi F, Bolhassani A. Generation of

GFP native protein for detection of its intracellular uptake by cell-penetrating

peptides. Folia biologica. 2016 May 1;62(3):103.

51. Mirzaie ZH, Irani S, Mirfakhraie R, Atyabi SM, Dinarvand M, Dinarvand R,

Varshochian R, Atyabi F. Docetaxel–Chitosan nanoparticles for breast cancer

treatment: cell viability and gene expression study. Chemical biology & drug

design. 2016 Dec;88(6):850-8. IF:2.256

52. Sadeghi S, Khorrami M, Amin-Beidokhti M, Abbasi M, Kamalian Z, Irani S,

Omrani M, Azmoodeh O, Mirfakhraie R. The study of MED12 gene

mutations in uterine leiomyomas from Iranian patients. Tumor Biology. 2016

Feb 1;37(2):1567-71. IF:3.650

53. Ansari MH, Irani S, Edalat H, Amin R, Roushandeh AM. Deregulation of

miR-93 and miR-143 in human esophageal cancer. Tumor Biology. 2016 Mar

1;37(3):3097-103. IF:3.650

Page 8: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

54. Keivani F, Shokrollahi P, Zandi M, Irani S, Shokrolahi F, Khorasani SC.

Engineered electrospun poly (caprolactone)/polycaprolactone-g-

hydroxyapatite nano-fibrous scaffold promotes human fibroblasts adhesion

and proliferation. Materials Science and Engineering: C. 2016 Nov 1;68:78-

88. IF:5.08

55. Atyabi SM, Sharifi F, Irani S, Zandi M, Mivehchi H, Nagheh Z. Cell

attachment and viability study of PCL nano-fiber modified by cold

atmospheric plasma. Cell biochemistry and biophysics. 2016 Jun

1;74(2):181-90. IF:1.455

56. Jalili A, Irani S, Mirfakhraie R. Combination of cold atmospheric plasma and

iron nanoparticles in breast cancer: Gene expression and apoptosis study.

OncoTargets and therapy. 2016;9:5911. IF: 2.311

57. Azam Soleimani, Kourosh ghanadi, Zahra Noormohammadi, Shiva Irani.,

The correlation between MiR146-a C/G polymorphism and UHFR1 gene

expression level in gastric tumor., Journal of Digestive Diseases., 2016;17(3):

169-74., IF:1.9

58. MT. Akbari, A. Naderi, L. Saremi, A. Sayad, S. Irani, A. Ahani., Methionine

synthase A2756G variation is associated with risk of reitinoblastoma in

Iranian children., Cancer Epidemiology, 2015; 39: 1023-1025, IF: 2.711

59. Maryam Peymani, Kamran Ghaedi, Shiva Irani, Mohammad Hossein Nasr

Esfehani., Peroxisome proliferator-activator receptor gamma activity is required for

appropriate ardiomyocyte differentiation., Cell Journal., 2016;18(2): 221-228, IF:

1.05

60. S Sadeghi, M Khorrami, M Amin-Beidokhti, M Abbasi, S.Irani , et al, The study of MED12 gene mutations in uterine leiomyomas from Iranian patients,

Tumor Biology, 2015, 1-5, IF: 3.661

61. MH Ansari, S Irani, H Edalat, R Amin, AM Roushandeh., Deregulation of miR-93

and miR-143 in human esophageal cancer., Tumor Biology, 2015: 1-7, IF: 3.661

62. Seyyedeh Masumeh Mirnurollahi, Azam Bolhassani, Shiva Irani, Noushin

Davoudi., Expression and Purification of HCV Core and Core-E1E2 Proteins in

Different Bacterial Strains., Iranian Journal of Biotechnology., 2015; 13(3): 57-62.,

IF: 0.375

63. Marzieh Kordezangeneh, Shiva Irani, Reza Mirfakhraie, Mehdi Esfandyari-

Manesh ,Fatemeh Atyabi, Rassoul Dinarvand., Regulation of BAX/BCL2

gene expression in breast cancer cells by docetaxel loaded human serum

albumin nanoparticles. Medical oncology. 2015: 32; 1-9., IF: 2.66

64. SM Saeed, H Mirzadeh, M Zandi, S Irani, J Barzin., Rationalization of

specific structure formation in electrospinning process: Study on nano‐fibrous

Page 9: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

PCL and PLGA based scaffolds., Journal of Biomedical Materials Research

Part A. 2015; 77(3): 280-287., IF: 3.369

65. Marjan Taheri, Ahmad Salamian, Kamran Ghaedi, Maryam Peymani,

Tayebeh Izadi, Alireza Shoaraye Nejati, Atefeh Atefi, Marzieh Nematollahi,

Fatemeh Ahmadi Ghahrizjani, Maryam Esmaeili, Abbas Kiani Esfahani,

Shiva Irani, Hossein Baharvand, Mohammad Hossein Nasr-Esfahani., A

ground state of PPARγ activity and expression is required for appropriate

neural differentiation of hESCs., Pharmacological Reports. 2015;67: 1103-

1114., IF: 1.928 66. A Behrouzi, S Bouzari, SD Siadat, A Jafari, S Irani, Molecular Cloning, Expression

and Purification of Truncated hpd Fragment of Haemophilus influenzae in

Escherichia coli, Jundishapur journal of microbiology, 2015;8(8), 1-6, IF: 0.73

67. Isar Dejban Golpasha, Seyed Fazlollah Mousavi, Parviz Owila, Seyed Davar Siadat,

Shiva Irani, Recombinant PcrV induced poly-isotypic humoral immune

responses against pseudomonas aeruginosa in BALB/c mice, Journal of

pured applied microbiology, 2015, 95-945.

68. SM Mirnoorollahi, S.Irani, N. Davoudi, A. Bolhassani., Different protein expression

systems can influence the direction of the immune responses against HCV core

protein in animal model., Vaccine Research., 2015;2(4): 54-58.

69. Seyed Ataollah Sadat Shandiz, Mehdi Shafiee Aedestani, Shiva Irani,

Delavar Shahbazzadeh., up-regulationof 23nm, metastasis suppressor gene in

human prostat adenocarcinoma cell line treated by imitanib.,Journal of

Isfahan medical school., 2015; 32:309.

70. Mojgan Broumand, Shiva Irani, Seyed Davar Siadat, Saeed Bouzari.

Molecular detection of genomic islands associated with class1 and 2 integron

in haemophilus influezae isolated in Iran. Jundishapoor journal of

microbiology. 2015; 8:4, 17249. IF=0.78

71. Isar Dejban Golpasha, Seyed Fazlollah Mousavi, Parviz Owlia, Seyed Davar

Siadat, Shiva Irani. Immunization with 3-oxododecanoyl-L-homoserine-r-

PcrV conjugate enhances survival of mice against lethal burn infections

caused by Pseudomonas aeroginosa. Bosnian journal of basic medical

science, 2015; 15(2):15-24. IF= 0.45

72. Shiva.Irani, Zohreh Shahmirani, Seyed Mohammad Atyabi, Shahriar

Mirpoor., Induction of growth arrest in colorectal cancer cells by cold plasma

and goldnanoparticles., Archive of Medical Science.2015; 11:6. IF= 2.06

73. A Mohammadi, S Irani, SM Atyabi , Study of breast cancer cells inhibition by cold

atmospheric plasma, Medical Science Journal of Islamic Azad Univesity, 2015

25(2), 125-131.

Page 10: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

74. Sayeh Atoon, Shiva Irani, Morteza Daliri Joupari, M.Taghi Khorasani,

Biocompatibility study of Chitosan/ Laminin scaffolds. Ncmbj, 2014, 4:16,

49-55.

75. Naghmeh Ezzati, Shiva Irani, Seyed Mohammad Atyabi, Study of fibroblast

cells proliferation in electromagnetic field. Kermanshah University Medical

Science. 2014, 18:11, 612-618.

76. Fereshteh Sharifi, Shiva Irani, Mojgan Zandi, Masoud Soleimani, Synthesis

and surface modification of polycaprolactone nanofibers for tissue

engineering. Ardabil Medical Journal., Accepted

77. Khadijeh fanai, Hamidreza Mozhgani, Shiva Irani, Alireza.Gholami, Design,

construction expression of recombinant vector containing the rabies virus

nucleoprotein gene, Tehran University Medical Science. Accepted

78. Zeynab Samari, Shiva Irani, Seyed Davar Siadat., molecular epidemiology

of ompps in hemophilus influenza spp in clinical isolated. Minerva

Biotechnologica., 2015; 27: 163-70

79. Ava Behrouzi, Saeed Bouzari, Seyed Davar Siadat, Shiva Irani, In silico

studies of outer membrane of neisseria meningitides por: its expression and

immunogenic. International Journal of Molecular Medicine, 2014, 3:3.

80. Ehsan Sharifipour, Mohammad Javad Nasiri, Parisa Farnia, Mohadeseh

Mozafari, Shiva Irani, Ali Akbar Velayati., Evaluation of molecular

diversity of Mycobacterium tuberculosis strains by polymorphisms in RD

regions., j mycobac Dis 2014, 4:3, 1-4

81. Z.Shahmirani, S.Irani, SM.Atyabi, S.mirpour, S.Shadpour,m.Ghorannevis,

m.Daliri joupari. Annual research and review in biology. 2014; 4:20, 3108-

3118.

82. Shiva Irani, Saye Atoon, Mohammad Taghi Khorasani, Morteza Daliri

Joupari. Fibroblast cell behavior study on chitosan/laminin scaffolds for

tissue engineering. Minerva Biotechnologica. Accepted

83. Shiva Irani, Mojgan zandi, Najmeh Salamian, Seyed Mahdi Saeed, Morteza

Daliri Joupari, Seyed Mohammad Atyabi., The study of p19 stem cell

behavior on alighned oriented electrospun poly(Lactic-co-glycolic acid)

nano-fibers for neural tissue engineering, Polymer advanced technology,

2014;25: 562-567. IF= 1.635

84. Zahra Gorzin, Ali Akbar Gorzin, Alijan Tabarraei, Naser Behnampour, Shiva

Irani, Amir Ghaem., Immunogenicity Evaluation of a DNA Vaccine

Expressing the Hepatitis C Virus Non-Structural Protein 2 Gene in C57BL/6

Mice., Iranian Biomedical Journal, 2014;18(1),1-7

85. Hadi Bakhshi, Hamid Yeganeh, Shahram Mehdipoor Atai, Atefeh Solouk,

Shiva Irani.,Polyuretane coatings derived from 1,2,3- triazole-functionalized

Page 11: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

oil-based polyols: studing their physical, mechanical, thermal and

biological., Macromolecules 2013;46, 7777-7788. IF= 5.521

86. Marzieh Hedayati, Shiva Irani, Mojgan zandi, Seyed Mahdi Saeed, Seyed

Mohammad Atyabi ,preparation of electrospun nanofibrous PLGA / gelatin

for tissue engineering., Medical journal of Tabriz University., 2013;35(5), 82-

87.

87. Mohammad R. Aghasadeghi, Hossein Heidari, Seyed M. Sadat, Shiva Irani

,Seyed D. Siadat, Mohammad E. Fazlhashemy, Rezvan Zabihollahi, Safieh

Amini, Seyed M. Atyabi,Seyed B. Momen, Mohammad S. Khosraavy, Mehdi

Davari, Tahmineh Darvishmohammadi Mohammad Doroudian, Mehdi S.

Ardestani. Lamivudine-PEGylated chitosan: A novel effective nanosized

antiretroviral agent. Current HIV Research, 2013,;11, 309-320. IF= 2

88. E.Asgharkhani, A.Akbarzadeh, Mohsen Chiani, Shiva Irani, Seyed

Mohammad Atyabi, Darioush Norouzian. Investigation of Artemisinin

nanonisomes cytotoxicity effect on breast cancer cells. Iranian journal of

Breast Diseases, 5(4)2013, 7-12.

89. Seyedeh-Najmeh Katebi, Yasaman Razavi, Shabnam Zeighami Alamdary,

Shiva Irani, Fariba Khodagholi, Abbas Haghparast., Effect of insulin-like

growth factor-1 on apoptosis in Chinese hamster ovary cells for

biopharmaceutical production., 2013; 22(4), 251-258.

90. Najmeh Salamian, Shiva Irani, Mojgan zandi, Seyed Mahdi Saeed, Seyed

Mohammad Atyabi., PLGA substrate nanostructured prepared through

electrospinning and freeze drying to tissue engineering., Cell & Tissue

journal., 2013; 4(3), 251-260

91. M.sadat Shojaie, MT.Khorasani, A.Jamshidi, S.Irani. Nano-hydroxyapatite

reinforced polyhydroxybutyrate composite: A comparative study on the

structural and in vitro biological properties. Materials Science and

Engineering:C, 2013; 33(5), 2776-2787,. IF=2.349

92. Najmeh salamian, Shiva Irani, et al. Cell attachment studies on electrospun

nanofibrous PLGA and freeze-dried porous PLGA. Nano Bulletin, 2013; 2,

(1).

93. Shiva Irani, Marzieh Hedayati, et al. A comparative study of cell behavior

on PLGA, gelatin and PLGA/gelatin scaffolds. Nano Bulletin, .2013; 2, (2).

94. H.Heidari, Shiva Irani, et al. Construction and evaluation of the

physicochemical composition of chitosan nanoparticles loaded with

drug lamivudine Pgylh., Arak Medical University Journal, 2013; 16(6),.

Page 12: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

95. Somayeh Piroozmand, Shiva Irani, et al, Effect of insulin like growth factor

I on apoptosis in Chinese Hamster ovary cells for biopharmaceutical

production. Medical science journal of Islamic Azad University, 2013; 22(4),

251-258.

96. S.Mirmohammadi, M.Khorasani, H.Mirzadeh, Shiva Irani, Investigation of

plasma treatment on poly(3-hydroxybutyrate) film surface: characterization

and invitro assay., Polymer-Plastics Technology and engineering journal.,

2012; 51:1319-1326,. IF= 1.481

97. J.Raheb, B.Radesh, Shiva Irani, et al, The study of biodesulfurization

activity in recombinant E.coli strain by cloning the dsz genes involve in 4s

pathway., Journal of science, 2011;22(3), 213-219.,.

98. Shiva Irani, SM.Atyabi,et al, Solvent effects on structural and

thermochemical properties of P53 Tumor-suppressor: A molecular modeling

approach in drug design., International journal of nanomedicine.,2011(6),

IF= 3.463

99. S.Irani, S.M.Atyabi, B.Honarparvar, M.Monajjemi, Investigation of solvent

effect&NMR shielding tensors of p53 tumor supressor gene to drug design,

International journal of nanomedicine.,2011(6), 213-218. IF=3.463

100. M.Khorasani., M.Mirmohammadi., S.Irani.,

Polyhydroxybutyrate(PHB) scaffolds as a model for nerve tissue engineering

application: fabrication and in vitro assay., International journal of polymeric

materials.2011,60(8) 562-575. IF=1.81

101. M.T Khorasani, H.Mirzadeh,Ali Talebi,Shiva Irani. Tubular scaffold

desighn of poly(l-lactic acid) for nerve tissue engineering:preparation,

characterization, and In Vitro assay., IPJ 2009;18(4),297-306. IF= 1.053

102. M.Khorasani, H.Mirzadeh, Shiva Irani,.comparison of fibroblast and

nerve cells response on plasma treated poly(l-lactide) surface., journal of

Applied Polymer Science, 2009;112:3429-3435. IF=1.40

103. M.T Khorasani, H.mirzadeh, Shiva Irani, Plasma surface modification

of poly (L-lactic acid) and poly (lactic-co-glycolic acid) films for

improvement of nerve cells adhesion.Radiation physics and chemistry. 2007;

77(3),280-287. IF=1.375

104. M.T Khorasani, H. Mirzadeh, Shiva Irani, Seous plasma modification

of amorphous poly (D, L lactic acid) film surface for nerve tissue engineering

purposes. Yakhteh medical journal.2007.

105. Shiva Irani, M.Monajjemi, S.M.Atyabi, M.Sadeghizadeh, M.heshmat.

Investigation of solvent effect on CUA codon mutation: NMR sheilding

study., Jphys.theor.chem, 2008; 5(1) 29-35,.

Page 13: Shiva Irani (B.Sc., M.Sc., PhD) Educational Qualifications: …faculty.srbiau.ac.ir/.../1563122377-cv-irani98-4.pdf · Shiva Irani (B.Sc., M.Sc., PhD) Science and Research Branch,

106. Shiva Irani,S.M.Atyabi, A.haddadi, M.monajjemi-study of

dielectric&solvent effect on mutation of CUA codon in p53 gene.IBJ.2007.

107. A.Haddadi, F.Molla Amin, Shiva Irani, M.Monajjemi- Investigation

of dielectric&solvent effect on mutation of TAT codon from lac promoter:

NMR shielding and thermodynamic study.IBJ.2007.

108. M.Heshmat, S.Saki, M.Khaleghian, Shiva Irani, M.Monajjemi,

Investigation of solvent effect on the active site energy of carbonic anhydrase

and ribonucleotide reductase, Journal of physical and theoretical

chemistry5(11)9-13,2008

Conferences,

1. Zienab Samari, Shiva Irani, Seyed Davar Siadat, et al. Dtermination of

molecular epidemiology haemophilus influenza spp ompP5 in clinical

isolated. 13th

Iranian congress of Biochemistry& 5th

international congress of

b iochemistry and molecular biology. April 2013.

2. M. Hedayati, S.Irani, SM.Atyabi, M.Zandi, SM Saeed, H.Mirzadeh, Soft

tissue engineering with PLGA, gelatin and PLGA/GEL nano

scaffolds.International congres on nanoscience & nanotechnology, Iran, 2012

3. Seyedeh Najmeh Katebi, Yasaman Razavi,Shabnam Zeighamy Alamdary

,Shiva Irani, Fariba Khodagholi, Abbas Haghparast., Study of apoptosis in

the Ventral Tegmental Area and Prefrontal cortex in morphine-treated rat. The

6th

national congress on addiction biology, Iran,2012

4. E.Samei, S.Ganji, A.Sl, F.Rastegar, S.Irani., 12th

Iranian Genetics Congress,

Iran, 2012

5. M.T.Khorasani, S.A.Mirmohammadi, S.Irani, neuronal differentiation of p19

embryonal cells in polyhydroxybutyrate scaffold as a model for nerve tissue

engineering, proceedings of 7th

lasted international conference BioMed 2010,

Austria.

6. M.T. Khorasani., SA.Mirmoohammadi., H.Mirzadeh., S.Irani., Investigation

of gaseous plasma treatment on polyhydroxybutyrate film: characterize and

In-Vitro assay.4th

International symposium on macro and supramolecul.,

2008., Germany

7. M.T.Khorasani, H.Mirzadeh, Ali Talebi, S.Irani. Tubular scaffold desighn of

poly lactide acid for nerve tissue engineering:In Vitro, IFMBE proceedings 22,

pp.2285-2287,2008

8. S.M.Atyabi, S.Irani, J.Raheb- Isolation, cloning and expression of

monooxigenase gene from a newly isolated strain in Iran "׀nternathional

conference on environmental, industrial and applied microbiology, Badajoz,

Spain(BioMicroWorld2007).

9. M.T Khorasani, S.M.Atyabi, H.Mirzadeh, B.Sadatnia, S.Irani- Synthesis of

medium chain length polyhydroxyalkanoate (mclPHA) by a native

Pseudomonas strain, Tehran, Iran (ISPST2005).


Recommended